List of Excipients in API SOLIFENACIN SUCCINATE
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing SOLIFENACIN SUCCINATE
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Astellas Pharma US Inc | VESICARE | solifenacin succinate | 51248-250 | ACESULFAME POTASSIUM | |
| Astellas Pharma US Inc | VESICARE | solifenacin succinate | 51248-250 | CARBOMER HOMOPOLYMER TYPE | |
| Astellas Pharma US Inc | VESICARE | solifenacin succinate | 51248-250 | DIMETHICONE | |
| Astellas Pharma US Inc | VESICARE | solifenacin succinate | 51248-250 | METHYLPARABEN | |
| Astellas Pharma US Inc | VESICARE | solifenacin succinate | 51248-250 | POLACRILIN POTASSIUM | |
| Astellas Pharma US Inc | VESICARE | solifenacin succinate | 51248-250 | PROPYLENE GLYCOL | |
| Astellas Pharma US Inc | VESICARE | solifenacin succinate | 51248-250 | PROPYLPARABEN | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing SOLIFENACIN SUCCINATE
Detailed excipient profiles for SOLIFENACIN SUCCINATE
Excipient focus: ACESULFAME POTASSIUM
SOLIFENACIN SUCCINATE drug variants containing ACESULFAME POTASSIUM
| Company | Ingredient | NDC |
|---|---|---|
| Astellas Pharma US Inc | solifenacin succinate | 51248-250 |
| >Company | >Ingredient | >NDC |
SOLIFENACIN SUCCINATE drug variants not containing ACESULFAME POTASSIUM
Excipient focus: ANHYDROUS LACTOSE
SOLIFENACIN SUCCINATE drug variants containing ANHYDROUS LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | solifenacin succinate | 0093-5263 |
| Sunshine Lake Pharma Co Ltd | solifenacin succinate | 48792-7909 |
| >Company | >Ingredient | >NDC |
SOLIFENACIN SUCCINATE drug variants not containing ANHYDROUS LACTOSE
Excipient focus: BUTYLATED HYDROXYANISOLE
SOLIFENACIN SUCCINATE drug variants containing BUTYLATED HYDROXYANISOLE
| Company | Ingredient | NDC |
|---|---|---|
| Amneal Pharmaceuticals NY LLC | solifenacin succinate | 69238-1308 |
| >Company | >Ingredient | >NDC |
SOLIFENACIN SUCCINATE drug variants not containing BUTYLATED HYDROXYANISOLE
Excipient focus: CARBOMER HOMOPOLYMER TYPE
SOLIFENACIN SUCCINATE drug variants containing CARBOMER HOMOPOLYMER TYPE
| Company | Ingredient | NDC |
|---|---|---|
| Astellas Pharma US Inc | solifenacin succinate | 51248-250 |
| >Company | >Ingredient | >NDC |
SOLIFENACIN SUCCINATE drug variants not containing CARBOMER HOMOPOLYMER TYPE
Excipient focus: CELLULOSE, MICROCRYSTALLINE
SOLIFENACIN SUCCINATE drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | solifenacin succinate | 0093-5263 |
| Lannett Company Inc | solifenacin succinate | 0527-1933 |
| Sunshine Lake Pharma Co Ltd | solifenacin succinate | 48792-7909 |
| >Company | >Ingredient | >NDC |
SOLIFENACIN SUCCINATE drug variants not containing CELLULOSE, MICROCRYSTALLINE
Excipient focus: CROSPOVIDONE
SOLIFENACIN SUCCINATE drug variants containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | solifenacin succinate | 0093-5263 |
| >Company | >Ingredient | >NDC |
SOLIFENACIN SUCCINATE drug variants not containing CROSPOVIDONE
Excipient focus: D&C YELLOW NO. 10
SOLIFENACIN SUCCINATE drug variants containing D&C YELLOW NO. 10
| Company | Ingredient | NDC |
|---|---|---|
| Alembic Pharmaceuticals Limited | solifenacin succinate | 46708-192 |
| American Health Packaging | solifenacin succinate | 60687-499 |
| Alembic Pharmaceuticals Inc | solifenacin succinate | 62332-192 |
| >Company | >Ingredient | >NDC |
SOLIFENACIN SUCCINATE drug variants not containing D&C YELLOW NO. 10
Excipient focus: DIMETHICONE
SOLIFENACIN SUCCINATE drug variants containing DIMETHICONE
| Company | Ingredient | NDC |
|---|---|---|
| Astellas Pharma US Inc | solifenacin succinate | 51248-250 |
| >Company | >Ingredient | >NDC |
SOLIFENACIN SUCCINATE drug variants not containing DIMETHICONE
Excipient focus: FD&C YELLOW NO. 6
SOLIFENACIN SUCCINATE drug variants containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| Glenmark Pharmaceuticals Inc USA | solifenacin succinate | 68462-386 |
| >Company | >Ingredient | >NDC |
SOLIFENACIN SUCCINATE drug variants not containing FD&C YELLOW NO. 6
Excipient focus: FERRIC OXIDE RED
SOLIFENACIN SUCCINATE drug variants containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| Bryant Ranch Prepack | solifenacin succinate | 63629-8869 |
| Bryant Ranch Prepack | solifenacin succinate | 63629-8870 |
| Proficient Rx LP | solifenacin succinate | 71205-583 |
| Bryant Ranch Prepack | solifenacin succinate | 72162-1849 |
| Proficient Rx LP | solifenacin succinate | 82804-058 |
| >Company | >Ingredient | >NDC |
SOLIFENACIN SUCCINATE drug variants not containing FERRIC OXIDE RED
Excipient focus: FERRIC OXIDE YELLOW
SOLIFENACIN SUCCINATE drug variants containing FERRIC OXIDE YELLOW
SOLIFENACIN SUCCINATE drug variants not containing FERRIC OXIDE YELLOW
Excipient focus: HYPROMELLOSE
SOLIFENACIN SUCCINATE drug variants containing HYPROMELLOSE
SOLIFENACIN SUCCINATE drug variants not containing HYPROMELLOSE
Excipient focus: HYPROMELLOSE 2910
SOLIFENACIN SUCCINATE drug variants containing HYPROMELLOSE 2910
SOLIFENACIN SUCCINATE drug variants not containing HYPROMELLOSE 2910
Excipient focus: HYPROMELLOSES
SOLIFENACIN SUCCINATE drug variants containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Ajanta Pharma USA Inc | solifenacin succinate | 27241-037 |
| Macleods Pharmaceuticals Limited | solifenacin succinate | 33342-148 |
| Sunshine Lake Pharma Co Ltd | solifenacin succinate | 48792-7909 |
| MSN LABORATORIES PRIVATE LIMITED | solifenacin succinate | 69539-050 |
| >Company | >Ingredient | >NDC |
SOLIFENACIN SUCCINATE drug variants not containing HYPROMELLOSES
Excipient focus: LACTOSE MONOHYDRATE
SOLIFENACIN SUCCINATE drug variants containing LACTOSE MONOHYDRATE
SOLIFENACIN SUCCINATE drug variants not containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | solifenacin succinate | 0093-5263 |
| Astellas Pharma US Inc | solifenacin succinate | 51248-250 |
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
SOLIFENACIN SUCCINATE drug variants containing MAGNESIUM STEARATE
SOLIFENACIN SUCCINATE drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Astellas Pharma US Inc | solifenacin succinate | 51248-250 |
| >Company | >Ingredient | >NDC |
Excipient focus: MANNITOL
SOLIFENACIN SUCCINATE drug variants containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | solifenacin succinate | 0591-3795 |
| Proficient Rx LP | solifenacin succinate | 82804-058 |
| >Company | >Ingredient | >NDC |
SOLIFENACIN SUCCINATE drug variants not containing MANNITOL
Excipient focus: METHYLPARABEN
SOLIFENACIN SUCCINATE drug variants containing METHYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Astellas Pharma US Inc | solifenacin succinate | 51248-250 |
| >Company | >Ingredient | >NDC |
SOLIFENACIN SUCCINATE drug variants not containing METHYLPARABEN
Excipient focus: POLACRILIN POTASSIUM
SOLIFENACIN SUCCINATE drug variants containing POLACRILIN POTASSIUM
| Company | Ingredient | NDC |
|---|---|---|
| Astellas Pharma US Inc | solifenacin succinate | 51248-250 |
| >Company | >Ingredient | >NDC |
SOLIFENACIN SUCCINATE drug variants not containing POLACRILIN POTASSIUM
Excipient focus: POLYETHYLENE GLYCOL
SOLIFENACIN SUCCINATE drug variants containing POLYETHYLENE GLYCOL
SOLIFENACIN SUCCINATE drug variants not containing POLYETHYLENE GLYCOL
Excipient focus: POLYETHYLENE GLYCOL 1000
SOLIFENACIN SUCCINATE drug variants containing POLYETHYLENE GLYCOL 1000
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | solifenacin succinate | 0093-5263 |
| >Company | >Ingredient | >NDC |
SOLIFENACIN SUCCINATE drug variants not containing POLYETHYLENE GLYCOL 1000
Excipient focus: POLYETHYLENE GLYCOL 4000
SOLIFENACIN SUCCINATE drug variants containing POLYETHYLENE GLYCOL 4000
| Company | Ingredient | NDC |
|---|---|---|
| Aurobindo Pharma Limited | solifenacin succinate | 65862-878 |
| >Company | >Ingredient | >NDC |
SOLIFENACIN SUCCINATE drug variants not containing POLYETHYLENE GLYCOL 4000
Excipient focus: POLYETHYLENE GLYCOL 6000
SOLIFENACIN SUCCINATE drug variants containing POLYETHYLENE GLYCOL 6000
| Company | Ingredient | NDC |
|---|---|---|
| Proficient Rx LP | solifenacin succinate | 71205-583 |
| >Company | >Ingredient | >NDC |
SOLIFENACIN SUCCINATE drug variants not containing POLYETHYLENE GLYCOL 6000
Excipient focus: POLYETHYLENE GLYCOL 8000
SOLIFENACIN SUCCINATE drug variants containing POLYETHYLENE GLYCOL 8000
SOLIFENACIN SUCCINATE drug variants not containing POLYETHYLENE GLYCOL 8000
Excipient focus: POLYVINYL ALCOHOL
SOLIFENACIN SUCCINATE drug variants containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | solifenacin succinate | 0093-5263 |
| Graviti Pharmaceuticals Private Limited | solifenacin succinate | 69844-047 |
| >Company | >Ingredient | >NDC |
SOLIFENACIN SUCCINATE drug variants not containing POLYVINYL ALCOHOL
Excipient focus: POVIDONE
SOLIFENACIN SUCCINATE drug variants containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | solifenacin succinate | 0093-5263 |
| Actavis Pharma Inc | solifenacin succinate | 0591-3795 |
| Proficient Rx LP | solifenacin succinate | 82804-058 |
| >Company | >Ingredient | >NDC |
SOLIFENACIN SUCCINATE drug variants not containing POVIDONE
Excipient focus: PROPYL GALLATE
SOLIFENACIN SUCCINATE drug variants containing PROPYL GALLATE
| Company | Ingredient | NDC |
|---|---|---|
| Amneal Pharmaceuticals NY LLC | solifenacin succinate | 69238-1308 |
| >Company | >Ingredient | >NDC |
SOLIFENACIN SUCCINATE drug variants not containing PROPYL GALLATE
Excipient focus: PROPYLENE GLYCOL
SOLIFENACIN SUCCINATE drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Astellas Pharma US Inc | solifenacin succinate | 51248-250 |
| >Company | >Ingredient | >NDC |
SOLIFENACIN SUCCINATE drug variants not containing PROPYLENE GLYCOL
Excipient focus: PROPYLPARABEN
SOLIFENACIN SUCCINATE drug variants containing PROPYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Astellas Pharma US Inc | solifenacin succinate | 51248-250 |
| >Company | >Ingredient | >NDC |
SOLIFENACIN SUCCINATE drug variants not containing PROPYLPARABEN
Excipient focus: SILICON DIOXIDE
SOLIFENACIN SUCCINATE drug variants containing SILICON DIOXIDE
SOLIFENACIN SUCCINATE drug variants not containing SILICON DIOXIDE
Excipient focus: SODIUM HYDROXIDE
SOLIFENACIN SUCCINATE drug variants containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Astellas Pharma US Inc | solifenacin succinate | 51248-250 |
| >Company | >Ingredient | >NDC |
SOLIFENACIN SUCCINATE drug variants not containing SODIUM HYDROXIDE
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
SOLIFENACIN SUCCINATE drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | solifenacin succinate | 0591-3795 |
| Proficient Rx LP | solifenacin succinate | 82804-058 |
| >Company | >Ingredient | >NDC |
SOLIFENACIN SUCCINATE drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
Excipient focus: STARCH, CORN
SOLIFENACIN SUCCINATE drug variants containing STARCH, CORN
SOLIFENACIN SUCCINATE drug variants not containing STARCH, CORN
Excipient focus: TALC
SOLIFENACIN SUCCINATE drug variants containing TALC
SOLIFENACIN SUCCINATE drug variants not containing TALC
Excipient focus: TARTARIC ACID
SOLIFENACIN SUCCINATE drug variants containing TARTARIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Amneal Pharmaceuticals NY LLC | solifenacin succinate | 69238-1308 |
| >Company | >Ingredient | >NDC |
SOLIFENACIN SUCCINATE drug variants not containing TARTARIC ACID
Excipient focus: TITANIUM DIOXIDE
SOLIFENACIN SUCCINATE drug variants containing TITANIUM DIOXIDE
SOLIFENACIN SUCCINATE drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Astellas Pharma US Inc | solifenacin succinate | 51248-250 |
| >Company | >Ingredient | >NDC |
Excipient focus: TRIACETIN
SOLIFENACIN SUCCINATE drug variants containing TRIACETIN
SOLIFENACIN SUCCINATE drug variants not containing TRIACETIN
Excipient focus: WATER
SOLIFENACIN SUCCINATE drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Astellas Pharma US Inc | solifenacin succinate | 51248-250 |
| >Company | >Ingredient | >NDC |
SOLIFENACIN SUCCINATE drug variants not containing WATER
Excipient focus: XYLITOL
SOLIFENACIN SUCCINATE drug variants containing XYLITOL
| Company | Ingredient | NDC |
|---|---|---|
| Astellas Pharma US Inc | solifenacin succinate | 51248-250 |
| >Company | >Ingredient | >NDC |
SOLIFENACIN SUCCINATE drug variants not containing XYLITOL
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
